Millennium Management’s Calithera Biosciences, Inc CALA Stock Holding History

Millennium Management’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-32,160	Closed	-$260K	–	7841
2022 Q1	$260K	Buy	32,160 +6,065	+23%	+$62K	﹤0.01%	5670
2021 Q4	$347K	Sell	26,095 -10,862	-29%	-$273K	﹤0.01%	5394
2021 Q3	$1.61M	Sell	36,957 -23,675	-39%	-$1.02M	﹤0.01%	4158
2021 Q2	$2.53M	Buy	60,632 +48,658	+406%	+$2.14M	﹤0.01%	3660
2021 Q1	$580K	Buy	+11,974	New	+$697K	﹤0.01%	4702
2020 Q4	–	Sell	-8,745	Closed	-$603	–	5744
2020 Q3	$603	Sell	8,745 -13,770	-61%	-$1.2M	﹤0.01%	3477
2020 Q2	$2.38M	Buy	22,515 +20,744	+1,171%	+$2.46M	﹤0.01%	2396
2020 Q1	$157K	Sell	1,771 -15,339	-90%	-$1.83M	﹤0.01%	3465
2019 Q4	$1.95M	Buy	17,110 +10,751	+169%	+$809K	﹤0.01%	2634
2019 Q3	$392K	Buy	+6,359	New	+$509K	﹤0.01%	3412
2019 Q1	–	Sell	-3,163	Closed	-$254K	–	4449
2018 Q4	$254K	Buy	3,163 +389	+14%	+$38.4K	﹤0.01%	3302
2018 Q3	$291K	Sell	2,774 -3,229	-54%	-$307K	﹤0.01%	3495
2018 Q2	$600K	Sell	6,003 -29,654	-83%	-$3.36M	﹤0.01%	3082
2018 Q1	$4.49M	Sell	35,657 -36,322	-50%	-$5.66M	0.01%	1876
2017 Q4	$12M	Buy	71,979 +47,872	+199%	+$12.3M	0.02%	1208
2017 Q3	$7.59M	Buy	24,107 +12,628	+110%	+$3.98M	0.01%	1422
2017 Q2	$3.41M	Buy	11,479 +7,713	+205%	+$2.06M	0.01%	1751
2017 Q1	$870K	Buy	3,766 +3,190	+554%	+$551K	﹤0.01%	2480
2016 Q4	$37K	Sell	576 -4,538	-89%	-$283K	﹤0.01%	3266
2016 Q3	$332K	Buy	5,114 +257	+5%	+$16.6K	﹤0.01%	2777
2016 Q2	$360K	Buy	4,857 +3,832	+374%	+$384K	﹤0.01%	2649
2016 Q1	$116K	Sell	1,025 -212	-17%	-$24K	﹤0.01%	3061
2015 Q4	$190K	Buy	+1,237	New	+$186K	﹤0.01%	3109
2015 Q2	–	Sell	-1,262	Closed	-$414K	–	4003
2015 Q1	$414K	Sell	1,262 -12,901	-91%	-$4.59M	﹤0.01%	2851
2014 Q4	$5.72M	Buy	+14,163	New	+$3.7M	0.01%	1301

Other funds holding CALA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's CALA Position: Q2 2022 in Review

Millennium Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 32,160 shares — an estimated $260K sold.

Millennium Management first reported a position in CALA in Q4 2014 and held it in 25 quarters. The position peaked at $12M in Q4 2017. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

Millennium Management reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
Millennium Management sold 32,160 Calithera Biosciences, Inc shares in Q2 2022, an estimated $260K.
Millennium Management first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 25 quarters.
Millennium Management's Calithera Biosciences, Inc position peaked at $12M in Q4 2017.
28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.